Livent (LTHM) Stock Forecast, Price Target & Predictions
LTHM Stock Forecast
Livent stock forecast is as follows: an average price target of $27.33 (represents a 433.79% upside from LTHM’s last price of $5.12) and a rating consensus of 'Buy', based on 10 wall street analysts offering a 1-year stock forecast.
LTHM Price Target
The average price target for Livent (LTHM) is $27.33 based on 1-year price targets from 10 Wall Street analysts in the past 3 months, with a price target range of $30.00 to $25.00. This represents a potential 433.79% upside from LTHM's last price of $5.12.
LTHM Analyst Ratings
According to 10 Wall Street analysts, Livent's rating consensus is 'Buy'. The analyst rating breakdown for LTHM stock is 0 'Strong Buy' (0.00%), 7 'Buy' (70.00%), 3 'Hold' (30.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Livent Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| May 11, 2023 | Aleksey Yefremov | Loop Capital Markets | $30.00 | $25.60 | 17.19% | 485.94% |
| Oct 03, 2022 | Matthew DeYoe | Bank of America Securities | $27.00 | $30.07 | -10.21% | 427.34% |
| Aug 30, 2021 | David Deckelbaum | Cowen & Co. | $25.00 | $25.13 | -0.52% | 388.28% |
The latest Livent stock forecast, released on May 11, 2023 by Aleksey Yefremov from Loop Capital Markets, set a price target of $30.00, which represents a 17.19% increase from the stock price at the time of the forecast ($25.60), and a 485.94% increase from LTHM last price ($5.12).
Livent Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | - |
| Avg Price Target | - | - | - |
| Last Closing Price | $5.12 | $5.12 | $5.12 |
| Upside/Downside | -100.00% | -100.00% | -100.00% |
In the current month, the average price target of Livent stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Livent's last price of $5.12. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| May 17, 2023 | Goldman Sachs | Underperform | Buy | Upgrade |
| May 11, 2023 | Citigroup | - | Neutral | Initialise |
| May 11, 2023 | KeyBanc | - | Overweight | Upgrade |
| May 08, 2023 | CFRA | - | Buy | Upgrade |
| May 04, 2023 | CICC | - | Outperform | Upgrade |
| Apr 05, 2023 | Bank of America Securities | Neutral | Buy | Upgrade |
| Jan 11, 2023 | Exane BNP Paribas | - | Outperform | Upgrade |
| Jan 11, 2023 | Bank of America Securities | Buy | Neutral | Upgrade |
| Jan 11, 2023 | Bank of America Securities | Underperform | Buy | Upgrade |
| Jan 04, 2023 | Vertical Research | - | Buy | Upgrade |
Livent's last stock rating was published by Goldman Sachs on May 17, 2023. The company Upgrade its LTHM rating from "Underperform" to "Buy".
Livent Financial Forecast
Livent Revenue Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | $211.40M | $235.80M | $253.50M | $219.40M | $231.60M | $218.70M | $143.50M | $122.90M | $103.60M | $102.20M | $91.70M | $82.20M | $72.60M | $64.90M | $68.50M | $78.40M | $97.70M | $114.00M | $98.30M | $119.80M | $112.00M |
| Avg Forecast | $422.80M | $369.95M | $143.25M | $304.83M | $267.66M | $252.86M | $233.48M | $117.64M | $122.07M | $208.44M | $118.39M | $106.95M | $96.50M | $102.20M | $81.90M | $295.92M | $14.40M | $120.82M | $137.00M | $78.40M | $105.84M | $104.50M | $98.30M | $119.80M | $112.00M |
| High Forecast | $488.68M | $427.60M | $171.90M | $346.00M | $329.00M | $292.26M | $269.86M | $141.17M | $146.49M | $250.13M | $136.83M | $128.34M | $111.54M | $118.12M | $94.66M | $355.10M | $16.64M | $139.64M | $158.35M | $94.08M | $122.33M | $120.78M | $113.62M | $138.47M | $129.45M |
| Low Forecast | $377.06M | $329.92M | $114.60M | $285.00M | $244.00M | $225.50M | $208.22M | $94.12M | $97.66M | $166.75M | $105.58M | $85.56M | $86.06M | $91.14M | $73.04M | $236.74M | $12.84M | $107.74M | $122.18M | $62.72M | $94.39M | $93.19M | $87.66M | $106.84M | $99.88M |
| # Analysts | 2 | 2 | 4 | 7 | 10 | 9 | 9 | 18 | 13 | 12 | 8 | 10 | 9 | 6 | 6 | 12 | 9 | 8 | 9 | 16 | 7 | 7 | 8 | 13 | 8 |
| Surprise % | - | - | - | - | 0.79% | 0.93% | 1.09% | 1.86% | 1.90% | 1.05% | 1.21% | 1.15% | 1.07% | 1.00% | 1.12% | 0.28% | 5.04% | 0.54% | 0.50% | 1.00% | 0.92% | 1.09% | 1.00% | 1.00% | 1.00% |
Livent's average Quarter revenue forecast for Dec 23 based on 7 analysts is $304.83M, with a low forecast of $285.00M, and a high forecast of $346.00M. LTHM's average Quarter revenue forecast represents a 44.20% increase compared to the company's last Quarter revenue of $211.40M (Sep 23).
Livent EBITDA Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 4 | 7 | 10 | 9 | 9 | 18 | 13 | 12 | 8 | 10 | 9 | 6 | 6 | 12 | 9 | 8 | 9 | 16 | 7 | 7 | 8 | 13 | 8 |
| EBITDA | - | - | - | - | $110.60M | $100.60M | $140.60M | $91.30M | $100.00M | $93.40M | $59.00M | $23.40M | $9.00M | $10.30M | $6.60M | $3.30M | $-7.20M | $3.80M | $3.40M | $10.30M | $19.60M | $22.90M | $25.90M | $38.50M | $40.40M |
| Avg Forecast | $82.38M | $72.08M | $73.47M | $50.33M | $18.00M | $64.66M | $66.79M | $39.79M | $14.23M | $69.15M | $60.72M | $36.17M | $11.25M | $11.33M | $7.26M | $11.88M | $-45.36M | $7.07M | $4.59M | $10.30M | $21.11M | $20.82M | $25.90M | $38.50M | $40.40M |
| High Forecast | $95.21M | $83.31M | $88.17M | $60.40M | $21.60M | $77.59M | $80.15M | $47.75M | $17.08M | $82.98M | $72.86M | $43.41M | $13.50M | $13.60M | $8.71M | $14.26M | $-36.29M | $8.49M | $5.51M | $12.36M | $25.33M | $24.98M | $31.08M | $46.20M | $48.48M |
| Low Forecast | $73.46M | $64.28M | $58.78M | $40.27M | $14.40M | $51.73M | $53.43M | $31.83M | $11.38M | $55.32M | $48.58M | $28.94M | $9.00M | $9.06M | $5.81M | $9.50M | $-54.43M | $5.66M | $3.67M | $8.24M | $16.89M | $16.65M | $20.72M | $30.80M | $32.32M |
| Surprise % | - | - | - | - | 6.14% | 1.56% | 2.11% | 2.29% | 7.03% | 1.35% | 0.97% | 0.65% | 0.80% | 0.91% | 0.91% | 0.28% | 0.16% | 0.54% | 0.74% | 1.00% | 0.93% | 1.10% | 1.00% | 1.00% | 1.00% |
7 analysts predict LTHM's average Quarter EBITDA for Dec 23 to be $50.33M, with a high of $60.40M and a low of $40.27M. This is -54.49% lower than Livent's previous annual EBITDA (Sep 23) of $110.60M.
Livent Net Income Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 4 | 7 | 10 | 9 | 9 | 18 | 13 | 12 | 8 | 10 | 9 | 6 | 6 | 12 | 9 | 8 | 9 | 16 | 7 | 7 | 8 | 13 | 8 |
| Net Income | - | - | - | - | $87.40M | $90.20M | $114.80M | $82.70M | $77.60M | $60.00M | $53.20M | $7.50M | $-12.60M | $6.50M | $-800.00K | $-5.00M | $-11.80M | $-200.00K | $-1.90M | $-200.00K | $18.00M | $15.50M | $16.90M | $25.90M | $30.00M |
| Avg Forecast | $322.62M | $281.00M | $35.40M | $8.95M | $-25.20M | $43.01M | $32.19M | $7.07M | $-19.92M | $46.00M | $29.26M | $6.43M | $-15.75M | $7.15M | $-880.00K | $-18.00M | $-74.34M | $-372.31K | $-2.56M | $-200.00K | $19.38M | $14.09M | $16.90M | $25.90M | $30.00M |
| High Forecast | $359.84M | $313.43M | $42.49M | $10.73M | $-20.16M | $51.61M | $38.62M | $8.49M | $-15.94M | $55.20M | $35.11M | $7.71M | $-12.60M | $8.58M | $-704.00K | $-14.40M | $-59.47M | $-297.85K | $-2.05M | $-160.00K | $23.26M | $16.91M | $20.28M | $31.08M | $36.00M |
| Low Forecast | $279.19M | $243.18M | $28.32M | $7.16M | $-30.24M | $34.41M | $25.75M | $5.66M | $-23.91M | $36.80M | $23.41M | $5.14M | $-18.90M | $5.72M | $-1.06M | $-21.60M | $-89.21M | $-446.77K | $-3.08M | $-240.00K | $15.51M | $11.27M | $13.52M | $20.72M | $24.00M |
| Surprise % | - | - | - | - | -3.47% | 2.10% | 3.57% | 11.69% | -3.89% | 1.30% | 1.82% | 1.17% | 0.80% | 0.91% | 0.91% | 0.28% | 0.16% | 0.54% | 0.74% | 1.00% | 0.93% | 1.10% | 1.00% | 1.00% | 1.00% |
Livent's average Quarter net income forecast for Dec 23 is $8.95M, with a range of $7.16M to $10.73M. LTHM's average Quarter net income forecast represents a -89.77% decrease compared to the company's last Quarter net income of $87.40M (Sep 23).
Livent SG&A Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 4 | 7 | 10 | 9 | 9 | 18 | 13 | 12 | 8 | 10 | 9 | 6 | 6 | 12 | 9 | 8 | 9 | 16 | 7 | 7 | 8 | 13 | 8 |
| SG&A | - | - | - | - | $13.20M | $17.60M | $16.30M | $14.60M | $15.00M | $13.80M | $11.80M | $15.70M | $11.80M | $11.70M | $10.70M | $13.50M | $10.00M | $10.30M | $10.80M | $11.30M | $10.20M | $9.80M | $9.20M | $8.40M | $10.30M |
| Avg Forecast | $47.94M | $41.95M | $7.85M | $18.73M | $25.40M | $9.89M | $7.14M | $14.80M | $20.08M | $10.58M | $6.49M | $13.46M | $15.88M | $14.85M | $11.99M | $48.60M | $1.63M | $19.92M | $14.58M | $11.30M | $10.98M | $8.91M | $9.20M | $8.40M | $10.30M |
| High Forecast | $55.41M | $48.48M | $9.42M | $22.47M | $30.48M | $11.87M | $8.57M | $17.76M | $24.10M | $12.70M | $7.79M | $16.15M | $19.05M | $17.82M | $14.39M | $58.32M | $1.89M | $23.90M | $17.50M | $13.56M | $13.18M | $10.69M | $11.04M | $10.08M | $12.36M |
| Low Forecast | $42.75M | $37.41M | $6.28M | $14.98M | $20.32M | $7.91M | $5.71M | $11.84M | $16.07M | $8.46M | $5.19M | $10.77M | $12.70M | $11.88M | $9.59M | $38.88M | $1.46M | $15.93M | $11.66M | $9.04M | $8.79M | $7.13M | $7.36M | $6.72M | $8.24M |
| Surprise % | - | - | - | - | 0.52% | 1.78% | 2.28% | 0.99% | 0.75% | 1.30% | 1.82% | 1.17% | 0.74% | 0.79% | 0.89% | 0.28% | 6.12% | 0.52% | 0.74% | 1.00% | 0.93% | 1.10% | 1.00% | 1.00% | 1.00% |
Livent's average Quarter SG&A projection for Dec 23 is $18.73M, based on 7 Wall Street analysts, with a range of $14.98M to $22.47M. The forecast indicates a 41.86% rise compared to LTHM last annual SG&A of $13.20M (Sep 23).
Livent EPS Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 4 | 7 | 10 | 9 | 9 | 18 | 13 | 12 | 8 | 10 | 9 | 6 | 6 | 12 | 9 | 8 | 9 | 16 | 7 | 7 | 8 | 13 | 8 |
| EPS | - | - | - | - | $0.49 | $0.50 | $0.64 | $0.46 | $0.43 | $0.36 | $0.33 | $0.05 | $-0.08 | $0.04 | $-0.01 | $-0.03 | $-0.08 | - | $-0.01 | - | $0.12 | $0.11 | $0.12 | $0.18 | $0.21 |
| Avg Forecast | $1.54 | $1.34 | $1.58 | $0.52 | $0.48 | $0.47 | $0.39 | $1.95 | $0.40 | $0.29 | $0.14 | $1.89 | $0.02 | $0.02 | $0.01 | $0.04 | $-0.01 | $-0.00 | $0.01 | $0.05 | $0.13 | $0.11 | $0.12 | $0.23 | $0.22 |
| High Forecast | $1.72 | $1.50 | $1.76 | $0.58 | $0.53 | $0.52 | $0.43 | $2.18 | $0.45 | $0.32 | $0.16 | $2.11 | $0.03 | $0.02 | $0.01 | $0.04 | $-0.01 | $-0.00 | $0.02 | $0.06 | $0.14 | $0.12 | $0.13 | $0.26 | $0.25 |
| Low Forecast | $1.33 | $1.16 | $1.36 | $0.45 | $0.36 | $0.41 | $0.34 | $1.69 | $0.35 | $0.25 | $0.12 | $1.64 | $0.02 | $0.02 | $0.01 | $0.03 | $-0.00 | $-0.00 | $0.01 | $0.04 | $0.11 | $0.10 | $0.10 | $0.20 | $0.19 |
| Surprise % | - | - | - | - | 1.03% | 1.06% | 1.64% | 0.24% | 1.07% | 1.24% | 2.36% | 0.02% | -3.34% | 1.84% | -0.99% | -0.75% | 14.01% | - | -0.73% | - | 0.92% | 1.00% | 1.00% | 0.78% | 0.95% |
According to 7 Wall Street analysts, Livent's projected average Quarter EPS for Dec 23 is $0.52, with a low estimate of $0.45 and a high estimate of $0.58. This represents a 6.12% increase compared to LTHM previous annual EPS of $0.49 (Sep 23).
Livent Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| ALTO | Alto Ingredients | $1.37 | $3.50 | 155.47% | Buy |
| ALB | Albemarle | $103.53 | $184.55 | 78.26% | Buy |
| LTHM | Livent | $16.51 | $27.33 | 65.54% | Buy |
| PPG | PPG Industries | $122.53 | $160.65 | 31.11% | Buy |
| LYB | LyondellBasell Industries | $82.65 | $101.65 | 22.99% | Hold |
| SQM | Sociedad Química y Minera de Chile | $38.14 | $45.75 | 19.95% | Buy |
| DD | DuPont de Nemours | $81.85 | $93.29 | 13.98% | Buy |
| ECL | Ecolab | $245.24 | $253.25 | 3.27% | Buy |
| APD | Air Products and Chemicals | $317.10 | $315.87 | -0.39% | Buy |
| LIN | Linde | $449.10 | $426.24 | -5.09% | Buy |
| SHW | Sherwin-Williams Company | $378.99 | $354.89 | -6.36% | Buy |
| DNMR | Danimer Scientific | $8.64 | $0.90 | -89.58% | Hold |